Natalie J Colson1,2, Helen L Naug3,4, Elham Nikbakht3,4, Ping Zhang4, Joanna McCormack5. 1. School of Medical Science, Griffith University, Gold Coast, Australia. n.colson@griffith.edu.au. 2. Menzies Health Institute Queensland, Gold Coast, Australia. n.colson@griffith.edu.au. 3. School of Medical Science, Griffith University, Gold Coast, Australia. 4. Menzies Health Institute Queensland, Gold Coast, Australia. 5. School of Allied Health, Griffith University, Gold Coast, Australia.
Abstract
PURPOSE: Methylenetetrahydrofolate reductase (MTHFR) is a key folate pathway enzyme with the T variant of the MTHFR gene increasing the risk of low folate status, particularly coupled with low folate intake. As genetic variability of MTHFR influences folate status, it is important to ensure an adequate intake that overrides genetic effects but minimises any adverse effects. Our aim was to assess the influence of MTHFR genotype on folate status followed by response to supplementation. METHODS: We performed a meta-analysis of ten folate intervention studies to assess the degree to which MTHFR C677T genotype influenced plasma homocysteine and serum folate levels as measures of folate status. We then examined response after supplementation at intake values up to the upper tolerable limit. RESULTS: The MTHFR 677TT genotype was associated with higher plasma homocysteine (2.7 μmol/L, TT vs. CT/CC; 2.8 μmol/L, TT vs. CC) and lower serum folate (2.5 nmol/L, TT vs. CT/CC; 3.6 nmol/L, TT vs. CC). In two studies, the TT groups had mean plasma Hcy >15 μmol/L. Serum folate levels were >7 nmol/L for all genotype groups. After supplementation of 400 up to 1670 μg DFEs of folic acid or folic acid + fortified foods and/or natural food folates for a minimum of 4 weeks, there were no significant differences in plasma homocysteine levels; however, individuals with the TT genotype had a lower serum folate response to supplementation (7.2 nmol/L, TT vs. CT/CC; 8.7 nmol/L, TT vs. CC). CONCLUSIONS: This meta-analysis confirms observations from observational and intervention studies that MTHFR TT genotype is associated with increased plasma homocysteine and lowered serum folate and less response to short-term supplementation. The results can be used for modelling and guiding personalised intake recommendations for the nutrient folate.
PURPOSE:Methylenetetrahydrofolate reductase (MTHFR) is a key folate pathway enzyme with the T variant of the MTHFR gene increasing the risk of low folate status, particularly coupled with low folate intake. As genetic variability of MTHFR influences folate status, it is important to ensure an adequate intake that overrides genetic effects but minimises any adverse effects. Our aim was to assess the influence of MTHFR genotype on folate status followed by response to supplementation. METHODS: We performed a meta-analysis of ten folate intervention studies to assess the degree to which MTHFRC677T genotype influenced plasma homocysteine and serum folate levels as measures of folate status. We then examined response after supplementation at intake values up to the upper tolerable limit. RESULTS: The MTHFR 677TT genotype was associated with higher plasma homocysteine (2.7 μmol/L, TT vs. CT/CC; 2.8 μmol/L, TT vs. CC) and lower serum folate (2.5 nmol/L, TT vs. CT/CC; 3.6 nmol/L, TT vs. CC). In two studies, the TT groups had mean plasma Hcy >15 μmol/L. Serum folate levels were >7 nmol/L for all genotype groups. After supplementation of 400 up to 1670 μg DFEs of folic acid or folic acid + fortified foods and/or natural food folates for a minimum of 4 weeks, there were no significant differences in plasma homocysteine levels; however, individuals with the TT genotype had a lower serum folate response to supplementation (7.2 nmol/L, TT vs. CT/CC; 8.7 nmol/L, TT vs. CC). CONCLUSIONS: This meta-analysis confirms observations from observational and intervention studies that MTHFR TT genotype is associated with increased plasma homocysteine and lowered serum folate and less response to short-term supplementation. The results can be used for modelling and guiding personalised intake recommendations for the nutrient folate.
Authors: Martha E Payne; Brenda D Jamerson; Christopher F Potocky; Allison E Ashley-Koch; Marcy C Speer; David C Steffens Journal: J Nutr Elder Date: 2009-10
Authors: Aron M Troen; Breeana Mitchell; Bess Sorensen; Mark H Wener; Abbey Johnston; Brent Wood; Jacob Selhub; Anne McTiernan; Yutaka Yasui; Evrim Oral; John D Potter; Cornelia M Ulrich Journal: J Nutr Date: 2006-01 Impact factor: 4.798
Authors: M R Malinow; F J Nieto; W D Kruger; P B Duell; D L Hess; R A Gluckman; P C Block; C R Holzgang; P H Anderson; D Seltzer; B Upson; Q R Lin Journal: Arterioscler Thromb Vasc Biol Date: 1997-06 Impact factor: 8.311
Authors: B J Venn; J I Mann; S M Williams; L J Riddell; A Chisholm; M J Harper; W Aitken; J I Rossaak Journal: Eur J Clin Nutr Date: 2002-08 Impact factor: 4.016
Authors: Cheryl L Guinotte; Michael G Burns; Juan A Axume; Hiroko Hata; Tania F Urrutia; Aaron Alamilla; Dale McCabe; Anny Singgih; Edward A Cogger; Marie A Caudill Journal: J Nutr Date: 2003-05 Impact factor: 4.798
Authors: C S Yajnik; S S Deshpande; A A Jackson; H Refsum; S Rao; D J Fisher; D S Bhat; S S Naik; K J Coyaji; C V Joglekar; N Joshi; H G Lubree; V U Deshpande; S S Rege; C H D Fall Journal: Diabetologia Date: 2007-09-13 Impact factor: 10.122
Authors: Luigi Barrea; Giuseppe Annunziata; Laura Bordoni; Giovanna Muscogiuri; Annamaria Colao; Silvia Savastano Journal: Int J Obes Suppl Date: 2020-07-20
Authors: Chiara Grasso; Maja Popovic; Elena Isaevska; Fulvio Lazzarato; Valentina Fiano; Daniela Zugna; John Pluta; Benita Weathers; Kurt D'Andrea; Kristian Almstrup; Lynn Anson-Cartwright; D Timothy Bishop; Stephen J Chanock; Chu Chen; Victoria K Cortessis; Marlene D Dalgaard; Siamak Daneshmand; Alberto Ferlin; Carlo Foresta; Megan N Frone; Marija Gamulin; Jourik A Gietema; Mark H Greene; Tom Grotmol; Robert J Hamilton; Trine B Haugen; Russ Hauser; Robert Karlsson; Lambertus A Kiemeney; Davor Lessel; Patrizia Lista; Ragnhild A Lothe; Chey Loveday; Coby Meijer; Kevin T Nead; Jérémie Nsengimana; Rolf I Skotheim; Clare Turnbull; David J Vaughn; Fredrik Wiklund; Tongzhang Zheng; Andrea Zitella; Stephen M Schwartz; Katherine A McGlynn; Peter A Kanetsky; Katherine L Nathanson; Lorenzo Richiardi Journal: Cancer Epidemiol Biomarkers Prev Date: 2022-09-02 Impact factor: 4.090
Authors: Gemma Rodriguez-Carnero; Paula M Lorenzo; Ana Canton-Blanco; Leire Mendizabal; Maddi Arregi; Mirella Zulueta; Laureano Simon; Manuel Macia-Cortiñas; Felipe F Casanueva; Ana B Crujeiras Journal: Nutrients Date: 2022-06-29 Impact factor: 6.706
Authors: Leopold K Fezeu; Veronique Ducros; Jean-Louis Guéant; Jean-Claude Guilland; Valentina A Andreeva; Serge Hercberg; Pilar Galan Journal: PLoS One Date: 2018-05-29 Impact factor: 3.240